Bausch + Lomb Co. (NYSE:BLCO – Get Rating) was the target of a significant decrease in short interest in March. As of March 15th, there was short interest totalling 7,010,000 shares, a decrease of 5.7% from the February 28th total of 7,430,000 shares. Based on an average daily volume of 382,700 shares, the days-to-cover ratio […]
Should You Buy or Sell Bausch + Lomb Stock? Get The Latest BLCO Stock Forecast, Price Target, Earnings Estimates, Headlines, Short Interest at MarketBeat.
Bausch + Lomb Co. (NYSE:BLCO – Get Rating) has earned an average recommendation of “Moderate Buy” from the sixteen analysts that are covering the company, Marketbeat reports. Five investment analysts have rated the stock with a hold rating and ten have given a buy rating to the company. The average 1-year price objective among brokerages […]
HC Wainwright restated their buy rating on shares of Bausch + Lomb (NYSE:BLCO – Get Rating) in a research report sent to investors on Thursday, Benzinga reports. HC Wainwright currently has a $21.00 price objective on the stock. A number of other brokerages also recently issued reports on BLCO. Deutsche Bank Aktiengesellschaft lifted their price […]
Bausch Health Announces Fourth-Quarter and Full-Year 2022 Results streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.